Viewing Study NCT00000267


Ignite Creation Date: 2025-12-25 @ 12:33 AM
Ignite Modification Date: 2026-02-17 @ 9:40 PM
Study NCT ID: NCT00000267
Status: COMPLETED
Last Update Posted: 2017-01-12
First Post: 1999-09-20
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Risperidone Treatment in Dually-Diagnosed Individuals - 2
Sponsor: National Institute on Drug Abuse (NIDA)
Organization:

Organization Data

Organization:
Class: NIH
Study ID: NIDA-09236-2
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: NIH
Responsible Party:
Responsible Party Title:
Responsible Party Type: None
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators

Collaborators

Name Class View
None OTHER View